Thromb Haemost 1997; 77(06): 1179-1181
DOI: 10.1055/s-0038-1656134
Platelets
Schattauer GmbH Stuttgart

The Leu33/Pro Polymorphism (PIA1/PIA2 ) of the Glycoprotein IIIa (GPIIIa) Receptor Is Not Related to Myocardial Infarction in the ECTIM Study

Stefan-Martin Herrmann
The Institut National de la Santé et de la Recherche Médicale (Inserm) SC7, Paris
,
Odette Poirier
The Institut National de la Santé et de la Recherche Médicale (Inserm) SC7, Paris
,
Pedro Marques-Vidal
1   Monica Project Toulouse, France
,
Alun Evans
2   Monica Project Belfast, Northern Ireland, UK
,
Dominique Arveiler
3   Monica Project Strasbourg, Paris, France
,
Gerald Luc
4   Monica Project Lille, Paris, France
,
Joseph Emmerich
5   Hôpital Broussais, Paris, France
,
François Cambien
The Institut National de la Santé et de la Recherche Médicale (Inserm) SC7, Paris
› Author Affiliations
Further Information

Publication History

Received 25 October 1996

Accepted after resubmisssion 12 February 1997

Publication Date:
26 July 2018 (online)

Zoom Image

Summary

The GPIIb/IIIa receptor complex may contribute to acute coronary syndromes by mediating platelet aggregation. The Leu33/Pro polymorphism (PlAl/PlA2) of the GPIIIa has recently been shown to be associated with CHD in a small case-control study. We have investigated this polymorphism in a large multicenter study of patients with myocardial infarction and controls and found no difference in the distribution of allele and genotype frequencies between cases and controls.